Ectopic Pituitary Adenoma Diagnosis and Management

Ectopic pituitary adenomas are rare neuroendocrine tumours arising outside the sella turcica along the embryonic migratory path of pituitary cells. They can present anywhere from the nasopharynx to the clivus or sphenoid sinus, often with hormone hypersecretion or mass-effect symptoms. Diagnosis is challenging owing to normal intrasellar anatomy on routine imaging and non-specific endocrine tests. Multimodal assessment—including high-resolution magnetic resonance imaging, computed tomography, nuclear medicine scans and targeted suppression tests—is essential to localise the lesion and distinguish it from primary resistance syndromes or chordomas. Histopathological confirmation with immunohistochemistry remains the diagnostic gold standard. Management strategies are individualised and may include endoscopic transsphenoidal resection, medical therapy with somatostatin analogues or dopamine agonists for functional tumours, and radiotherapy for invasive or residual disease. Recent advances in epigenomic profiling and hybrid PET/MRI techniques have improved diagnostic confidence and guided precision treatment planning.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Ectopic Pituitary Adenoma Diagnosis and Management publication trend

The graph below shows the total number of articles in ectopic pituitary adenoma diagnosis and management across all publications each year (not limited to Nature Index journals).

Technical terms

Ectopic pituitary adenoma: A benign pituitary-cell tumour located outside the sella without connection to normal pituitary tissue.

68Ga-DOTATATE PET/CT: A nuclear imaging technique using a somatostatin analogue tracer to detect neuroendocrine tumours.

Octreotide suppression test: A dynamic endocrine assay measuring hormone suppression after administration of a somatostatin analogue to identify secretory pituitary tissue.

Transsphenoidal surgery: A minimally invasive endonasal approach to resect pituitary or adjacent skull-base tumours.

Epigenomic profiling: Genome-wide analysis of DNA methylation patterns to classify tumour origin and subtype.

Immunohistochemistry: Laboratory technique using antibodies to detect specific hormone or protein markers in tumour tissue.

References

1. Comparative epigenomics indicate a common origin of ectopic and intrasellar corticotroph pituitary neuroendocrine tumors/adenomas: a case report. Virchows Archiv (2024).
2. Central hyperthyroidism due to an ectopic TSH-secreting pituitary tumor: a case report and literature review. Frontiers in Endocrinology (2024).
3. Endoscopic transsphenoidal resection of a non-functioning ectopic pituitary adenoma located in the clivus: a case report and literature review. Egyptian Journal of Neurosurgery (2023).